Prof Xin Lu honoured by the Royal Society

30 April 2020

Magdalen Supernumerary Fellow Professor Xin Lu has been elected as a Fellow of the Royal Society, the UK’s distinguished academy of science, for her contributions to cancer biology. Professor Lu is the Director of the Ludwig Institute for Cancer Research, Oxford Branch.

Xin Lu is a cancer biologist distinguished by her contributions to understanding cellular pathways that control cell fate in development and disease, particularly cancer. She has a long-standing interest in how to selectively kill cancer cells, and her major research advances have provided insights into how the most mutated or inactivated tumour suppressor in human cancers, can make life or death decisions for a cell. Find out more about Xin’s research here.

In addition to her research, Xin plays a crucial role in helping to shape the cancer research landscape at Oxford through her Directorship of the Oxford Branch of the Ludwig Institute for Cancer Research, co-Directorship of the CRUK Oxford Centre, Cancer Theme leadership for the NIHR Oxford Biomedical Research Centre, and Directorship of the Oxford Centre for Early Cancer Detection. Xin is also a Fellow of the Academy of Medical Sciences and the Royal Society of Biology, a Fellow by election of the Royal College of Pathologists, and a Member of the European Molecular Biology Organisation.

“I am humbled to receive this honour from the Royal Society,” said Professor Lu. “As someone who barely spoke English at the beginning of my scientific career, I am hugely grateful for all the support I have received from my supervisors and mentors. My appreciation also goes to the Ludwig Institute for Cancer Research for its long-term research funding and to the Department, College, and University for a supportive and creative environment. Most important of all, my deep gratitude goes to the fantastic scientists in my laboratory, and colleagues I’ve had the privilege to work with throughout my career to date, without whom this recognition would not have been possible.” You can read more on the Ludwig Cancer Research website.